Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients
Clinical trial NCT04492254 · TERMINATED
Trial details
- NCT number
- NCT04492254
- Sponsor
- Thrombosis Research Institute
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-27
- Primary completion
- 2021-11-29
- Enrollment
- 219
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.